References
- Mikkelsen S. L., Ash K. O. Adulterants causing false negatives in illicit drug tests. Clin Chem 1988; 34: 2333–2336
- Cody J. T. Specimen adulteration in drug analysis. For Sci Rev 1990; 2: 63–75
- Schwarzhoff R., Cody J. T. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. J Anal Toxicol 1993; 17: 14–17
- Edwards C., Fyfe M. J., Liu R. H., Walia A. S. Evaluation of common urine specimen adulteration indicators. J Anal Toxicol 1993; 17: 251–252
- Wu A., Schmalz J., Bennett W. Identification of UrinAid-adulterated urine specimens by fluorometric analysis. Clin Chem 1994; 40: 845–846
- Soper J. W., Canfield D. V. Description of a screening assay system to detect adulteration of urine samples. J Anal Toxicol 1996; 20: 77
- George S., Braithwaite R. A. The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs-of-abuse assays. J Anal Toxicol 1996; 20: 195–196
- Lafolie P., Beck O., Blennow G., et al. Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem 1991; 37: 1927–1931
- Needleman S. B., Porvaznik M., Ander D. Creatinine analysis in single collection urine specimens. J Forensic Sci 1992; 37: 1125–1133
- Cone E. J., Darwin D., Holicky B., Willis R., Lange R. Beating the urine test for cocaine and marijuana with herbal teas and water loading. Presented at the Annual Meeting of the American Academy of Forensic Sciences, San Antonio, TX, February, 171994
- Baselt R. C. Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology2nd ed. PSG Publishing Company, Litteton, MA 1987; 24, 67, 95, 192
- Clinical Guide to Laboratory Tests, M. W. Tietz. W. B. Saunders Company, Philadelphia 1983; 378, 452
- Huestis M. A., Cone E. J. Urine creatinine levels in random and daily drug urine collections in a controlled clinical study. Presented at the Annual Meeting of the Society of Forensic Toxicologists, Phoenix, AZ, October, 151993